Total Payments
$619,046
2024 Payments
$146,066
Companies
35
Transactions
1,231
Payment Breakdown by Category
Other$484,347 (78.2%)
Consulting$74,950 (12.1%)
Travel$36,879 (6.0%)
Food & Beverage$22,223 (3.6%)
Education$627.74 (0.1%)
Gifts$20.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $436,428 | 218 | 70.5% |
| Consulting Fee | $74,950 | 34 | 12.1% |
| Honoraria | $40,700 | 21 | 6.6% |
| Travel and Lodging | $36,879 | 200 | 6.0% |
| Food and Beverage | $22,223 | 744 | 3.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $7,219 | 3 | 1.2% |
| Education | $627.74 | 10 | 0.1% |
| Gift | $20.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $143,617 | 287 | $0 (2024) |
| Alkermes, Inc. | $109,105 | 104 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $105,317 | 117 | $0 (2024) |
| Axsome Therapeutics, Inc. | $61,925 | 57 | $0 (2024) |
| Tris Pharma Inc | $46,847 | 100 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $36,178 | 55 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $31,030 | 33 | $0 (2017) |
| Neos Therapeutics, LP | $24,405 | 72 | $0 (2024) |
| Shire North American Group Inc | $23,897 | 60 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $16,995 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $146,066 | 215 | Axsome Therapeutics, Inc. ($46,284) |
| 2023 | $111,255 | 182 | Alkermes, Inc. ($40,916) |
| 2022 | $113,287 | 192 | Supernus Pharmaceuticals, Inc. ($51,172) |
| 2021 | $65,622 | 126 | Supernus Pharmaceuticals, Inc. ($43,199) |
| 2020 | $10,529 | 25 | Teva Pharmaceuticals USA, Inc. ($10,273) |
| 2019 | $29,678 | 131 | Teva Pharmaceuticals USA, Inc. ($17,592) |
| 2018 | $72,557 | 182 | Teva Pharmaceuticals USA, Inc. ($18,294) |
| 2017 | $70,052 | 178 | Takeda Pharmaceuticals America, Inc. ($31,030) |
All Payment Transactions
1,231 individual payment records from CMS Open Payments — Page 3 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $45.55 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/11/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/11/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/11/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/11/2024 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Neurology | ||||||
| 09/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $45.55 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Travel and Lodging | In-kind items and services | $45.54 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 09/10/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $36.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/29/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/27/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/26/2024 | Noven Pharmaceuticals, Inc. | Xelstrym (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,706.25 | General |
| Category: ADHD | ||||||
| 08/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/22/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/22/2024 | Noven Pharmaceuticals, Inc. | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $110.66 | General |
| Category: ADHD | ||||||
| 08/22/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: CNS | ||||||
| 08/21/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/21/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $15.09 | General |
| Category: ADHD | ||||||
| 08/20/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: ADHD | ||||||
| 08/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Neuropsychiatry | ||||||
| 08/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $124.42 | General |
| Category: Neuropsychiatry | ||||||
| 08/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Travel and Lodging | In-kind items and services | $107.20 | General |
| Category: Neuropsychiatry | ||||||
| 08/14/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
About Dr. Mark Wright, M.D
Dr. Mark Wright, M.D is a Psychiatry healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1154448991.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Wright, M.D has received a total of $619,046 in payments from pharmaceutical and medical device companies, with $146,066 received in 2024. These payments were reported across 1,231 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($436,428).
Ad
Practice Information
- Specialty Psychiatry
- Location Lexington, KY
- Active Since 03/26/2007
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154448991
Products in Payments
- LYBALVI (Drug) $108,991
- QELBREE (Drug) $108,516
- AUSTEDO (Drug) $81,824
- Auvelity (Drug) $61,925
- Trintellix (Drug) $47,548
- INGREZZA (Drug) $36,178
- Qelbree (Drug) $30,601
- Adzenys XR-ODT (Drug) $24,328
- MYDAYIS (Drug) $23,788
- Dyanavel XR (Drug) $22,675
- Austedo XR (Drug) $22,282
- Quillichew ER (Drug) $14,309
- Quillivant (Drug) $9,821
- Xelstrym (Drug) $8,333
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $4,852
- VRAYLAR (Drug) $1,958
- REXULTI (Drug) $1,365
- SD809-TD (Drug) $627.81
- Azstarys (Drug) $472.47
- APLENZIN (Drug) $310.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Lexington
Dr. Steven Croley, Md, MD
Psychiatry — Payments: $111,876
Psychiatry $111,876
Syed Rizvi, M.d, M.D
Psychiatry — Payments: $17,719
Psychiatry $17,719
Dr. Paolo Cassano, Md, Phd, MD, PHD
Psychiatry — Payments: $12,649
Psychiatry $12,649
Kathleen Lundvall, Md, MD
Psychiatry — Payments: $9,100
Psychiatry $9,100
Dr. Getulio Tovar, M.d, M.D
Psychiatry — Payments: $9,055
Psychiatry $9,055
Mr. Saeed Hamid, M.d, M.D
Psychiatry — Payments: $8,148
Psychiatry $8,148